Amylyx Pharmaceuticals, Inc. (AMLX)
NASDAQ: AMLX · Real-Time Price · USD
29.85
+0.36 (1.22%)
Sep 28, 2026, 4:00 PM EDT - Market closed
Amylyx Pharmaceuticals Market Cap
Amylyx Pharmaceuticals has a market cap or net worth of $3.75 billion as of September 28, 2026. Its market cap has increased by 141.90% in one year.
Market Cap
3.75B
Enterprise Value
3.50B
1-Year Change
141.90%
Ranking
Category
Stock Price
$29.85
ChartMarket Cap Chart
Since the IPO on January 7, 2022, Amylyx Pharmaceuticals's market cap has increased from $1.07B to $3.75B, an increase of 250.41%. That is a compound annual growth rate of 30.39%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 28, 2026 | 3.75B | 182.41% |
| Dec 31, 2025 | 1.33B | 415.49% |
| Dec 31, 2024 | 257.35M | -74.11% |
| Dec 29, 2023 | 993.86M | -59.40% |
| Dec 30, 2022 | 2.45B | 128.97% |
| Jan 7, 2022 | 1.07B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Lantheus Holdings | 6.51B |
| Liquidia | 6.13B |
| Kiniksa Pharmaceuticals International, | 5.86B |
| Regencell Bioscience Holdings | 3.06B |
| HUTCHMED (China) | 2.49B |
| Supernus Pharmaceuticals | 2.48B |
| Trulieve Cannabis | 2.35B |
| Prestige Consumer Healthcare | 2.21B |